Market pulse › SN Genelab
SN Genelab
Today0 stories · 0 articles
Net tone–
Market checkDr Lal PathLabs −0.5%
Developing0 storylines
224 Sept
025 Sept
126 Sept
027 Sept
028 Sept
Broker call● mixedAlkem Labs: Hold on till growth gets a new boostCDMO and medtech segments are expected to supplement Alkem’s base-business growth over the long termAlkem LaboratoriesCDMO
Market move● mixedStocks to Watch for September 25: PB Fintech, Inox Green Energy, Dr Lal Path, JSW Cement and moreWaaree Clean Energy Solutions is entering India’s specialty gases businessDr Lal PathLabsWaaree EnergiesPB Fintech
Deal▲ bullishDr Lal PathLabs to buy 70% of SN Genelab; reports differ on deal valueDr Lal PathLabs will acquire a **70% stake** in SN GenelabDr Lal PathLabsHospitals